A deep learning system for predicting time to progression of diabetic retinopathy

Author:

Dai Ling,Sheng BinORCID,Chen Tingli,Wu Qiang,Liu RuhanORCID,Cai Chun,Wu Liang,Yang Dawei,Hamzah Haslina,Liu Yuexing,Wang XiangningORCID,Guan ZhouyuORCID,Yu Shujie,Li Tingyao,Tang Ziqi,Ran AnranORCID,Che HaoxuanORCID,Chen HaoORCID,Zheng Yingfeng,Shu Jia,Huang Shan,Wu Chan,Lin Shiqun,Liu Dan,Li Jiajia,Wang Zheyuan,Meng Ziyao,Shen Jie,Hou Xuhong,Deng Chenxin,Ruan Lei,Lu Feng,Chee Miaoli,Quek Ten Cheer,Srinivasan Ramyaa,Raman Rajiv,Sun XiaodongORCID,Wang Ya XingORCID,Wu Jiarui,Jin Hai,Dai Rongping,Shen DinggangORCID,Yang Xiaokang,Guo Minyi,Zhang Cuntai,Cheung Carol Y.,Tan Gavin Siew Wei,Tham Yih-ChungORCID,Cheng Ching-YuORCID,Li HuatingORCID,Wong Tien YinORCID,Jia WeipingORCID

Abstract

AbstractDiabetic retinopathy (DR) is the leading cause of preventable blindness worldwide. The risk of DR progression is highly variable among different individuals, making it difficult to predict risk and personalize screening intervals. We developed and validated a deep learning system (DeepDR Plus) to predict time to DR progression within 5 years solely from fundus images. First, we used 717,308 fundus images from 179,327 participants with diabetes to pretrain the system. Subsequently, we trained and validated the system with a multiethnic dataset comprising 118,868 images from 29,868 participants with diabetes. For predicting time to DR progression, the system achieved concordance indexes of 0.754–0.846 and integrated Brier scores of 0.153–0.241 for all times up to 5 years. Furthermore, we validated the system in real-world cohorts of participants with diabetes. The integration with clinical workflow could potentially extend the mean screening interval from 12 months to 31.97 months, and the percentage of participants recommended to be screened at 1–5 years was 30.62%, 20.00%, 19.63%, 11.85% and 17.89%, respectively, while delayed detection of progression to vision-threatening DR was 0.18%. Altogether, the DeepDR Plus system could predict individualized risk and time to DR progression over 5 years, potentially allowing personalized screening intervals.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3